OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production leverages Chinese hamster ovary (CHO) cells due to their robustness in expressing complex biologics. Improving these processes involves modifying various factors, including cell line selection, media ingredients, and bioreactor conditions. A key goal is to maximize antibody yield while lowering production costs and m